CD8A and neoplasm: Consistently, other clinical studies demonstrated the ability of high doses of RT to induce anti-tumor CD8+ T cells producing IFN-γ and other pro-inflammatory cytokines in the periphery (80–82), while preclinical studies reported the increase in CD8+ TILs producing cytokine and cytolytic enzymes after RT (83–86).